5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.82▼ | 1.82▼ | 1.82▼ | 1.86▼ | 1.92▼ |
MA10 | 1.85▼ | 1.85▼ | 1.86▼ | 1.81▼ | 1.86▼ |
MA20 | 1.87▼ | 1.87▼ | 1.88▼ | 1.97▼ | 2.32▼ |
MA50 | 1.85▼ | 1.82▼ | 1.87▼ | 1.89▼ | 8.49▼ |
MA100 | 1.85▼ | 2.04▼ | 2.00▼ | 2.39▼ | N/A |
MA200 | 2.10▼ | 1.91▼ | 1.92▼ | 7.49▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.016▼ | -0.014▼ | -0.010▼ | -0.009▼ | 0.954▲ |
RSI | 36.466▼ | 39.686▼ | 40.374▼ | 45.551▼ | 28.811▼ |
STOCH | 3.099▼ | 3.099▼ | 11.427▼ | 51.081 | 28.845 |
WILL %R | -96.774▼ | -96.774▼ | -96.774▼ | -77.853▼ | -82.166▼ |
CCI | -123.787▼ | -127.148▼ | -130.963▼ | -46.922 | -54.509 |
MA | $AMIX Price Crossed Below MA(7) | Set Alert |
Friday, May 16, 2025 09:33 AM
Autonomix Medical announced that it received a new patent titled controlled sympathectomy and micro-ablation systems and methods.
|
Thursday, May 15, 2025 05:30 AM
Patent strengthens Autonomix’s intellectual property position in the nerve-mapping and denervation space, supporting the Company’s broader mission to advance minimally invasive, nerve-focused ...
|
Wednesday, May 14, 2025 06:30 AM
THE WOODLANDS, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company focused on advancing precision nerve-targeted ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/05/25 | 1.78 | 1.825 | 1.76 | 1.80 | 30,900 |
20/05/25 | 1.865 | 1.865 | 1.77 | 1.79 | 68,200 |
19/05/25 | 1.94 | 1.94 | 1.86 | 1.87 | 65,568 |
16/05/25 | 1.81 | 1.95 | 1.81 | 1.95 | 175,635 |
15/05/25 | 1.77 | 1.96 | 1.75 | 1.90 | 3,483,800 |
14/05/25 | 1.77 | 1.77 | 1.67 | 1.74 | 57,585 |
13/05/25 | 1.75 | 1.90 | 1.75 | 1.85 | 82,800 |
12/05/25 | 1.82 | 1.84 | 1.675 | 1.75 | 116,658 |
09/05/25 | 1.69 | 1.78 | 1.68 | 1.78 | 38,600 |
08/05/25 | 1.81 | 1.844 | 1.68 | 1.70 | 48,705 |
|
|
||||
|
|
||||
|
|